Insurance barriers block oral blood cancer drug access, study finds
Insurance barriers block oral blood cancer drug access, study finds Insurance Business Insurance barriers block oral blood cancer drug access, study finds Most specialty oral blood cancer prescriptions submitted to US insurers are rejected on first attempt, and even when approved, a substantial share are never filled because the out-of-pocket…